Trial Profile
Safety of vedolizumab in patients with ulcerative colitis and Crohn's disease: A single-center study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions
- 19 Jan 2018 New trial record